Patient Preferences for Disease Modifying Anti-Rheumatic Drug Treatment of Rheumatoid Arthritis: A Systematic Review

被引：0
|
作者：
Durand, Caylib [1 ]
Eldoma, Maysoon [1 ]
Marshall, Deborah [1 ]
Hazlewood, Glen [1 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：889 / 889
页数：1
相关论文
共 50 条
  • [31] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [32] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [33] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [34] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Clélia Monchablon
    Henri Gondé
    Sophie Pouplin
    Rémi Varin
    Olivier Vittecoq
    Thierry Lequerré
    Clinical Rheumatology, 2020, 39 : 207 - 216
  • [35] ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Machado, J.
    Ruiz, A.
    Machado-Duque, M.
    VALUE IN HEALTH, 2015, 18 (03) : A153 - A153
  • [36] COMPARATIVE EFFECTIVENESS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN US VETERANS WITH RHEUMATOID ARTHRITIS
    Cannon, G. W.
    He, T.
    Teng, C. -C.
    Leng, J.
    Lu, C. -C.
    Tang, D.
    Shah, N.
    Harrison, D. J.
    Sauer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 446 - 447
  • [37] A PICTORIAL LEAFLET FOR COMBINED DISEASE-MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN EARLY RHEUMATOID ARTHRITIS
    Balendra, Salini
    Ahmed, Azeem
    Price, Elizabeth
    Collins, David
    Williamson, Lyn
    RHEUMATOLOGY, 2014, 53 : 121 - 121
  • [38] Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story
    Smolen, JS
    Graninger, WB
    Emery, P
    RHEUMATOLOGY, 2000, 39 (07) : 689 - 692
  • [39] PREDICTORS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG INITIATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN KOREA
    Park, E. H.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Song, Y. W.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 302 - 302
  • [40] Determinants and Impact of Early Initiation of Disease-Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
    Keshavamurthy, Chandana
    Kuriakose, Kevin
    Chandra, Deepak
    Kaur, Aneet
    Spencer, Horace
    Khan, Nasim A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1041 - S1041
12345